Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome

Cushing's syndrome is caused by excess cortisol production from the adrenocortical gland. In corticotropin-independent Cushing's syndrome, the excess cortisol production is primarily attributed to an adrenocortical adenoma, in which the underlying molecular pathogenesis has been poorly und...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science (American Association for the Advancement of Science) 2014-05, Vol.344 (6186), p.917-920
Hauptverfasser: Sato, Yusuke, Maekawa, Shigekatsu, Ishii, Ryohei, Sanada, Masashi, Morikawa, Teppei, Shiraishi, Yuichi, Yoshida, Kenichi, Nagata, Yasunobu, Sato-Otsubo, Aiko, Yoshizato, Tetsuichi, Suzuki, Hiromichi, Shiozawa, Yusuke, Kataoka, Keisuke, Kon, Ayana, Aoki, Kosuke, Chiba, Kenichi, Tanaka, Hiroko, Kume, Haruki, Miyano, Satoru, Fukayama, Masashi, Nureki, Osamu, Homma, Yukio, Ogawa, Seishi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Cushing's syndrome is caused by excess cortisol production from the adrenocortical gland. In corticotropin-independent Cushing's syndrome, the excess cortisol production is primarily attributed to an adrenocortical adenoma, in which the underlying molecular pathogenesis has been poorly understood. We report a hotspot mutation (L206R) in PRKACA, which encodes the catalytic subunit of cyclic adenosine monophosphate (cAMP)–dependent protein kinase (PKA), in more than 50% of cases with adrenocortical adenomas associated with corticotropin-independent Cushing's syndrome. The L206R PRKACA mutant abolished its binding to the regulatory subunit of PKA (PRKAR1A) that inhibits catalytic activity of PRKACA, leading to constitutive, cAMP-independent PKA activation. These results highlight the major role of cAMP-independent activation of cAMP/PKA signaling by somatic mutations in corticotropin-independent Cushing's syndrome, providing insights into the diagnosis and therapeutics of this syndrome.
ISSN:0036-8075
1095-9203
DOI:10.1126/science.1252328